Furthermore, in the subgroup analyses of CRC prognosis, we found that PBX3 hypermethylation was associated with better 10‐years OS in the male, normal weight, colon, and UICC stage III subgroups (Figure 3). The gene discussed is PBX3; the disease is colorectal carcinoma.